Compound
Compound is a New York-based, thesis-driven venture capital firm investing across AI/ML, biology, crypto, and robotics. It serves technical founders with capital and specialist Venture Partner support, publishes 100+ public investment theses, and operates a non-dilutive micro-grants program.
- Company typePrivate
- Founded2008
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Compound does
Compound is a thesis-driven, research-centric venture capital firm founded in 2016 and headquartered at 414 Broadway, New York. The firm invests across six explicit thesis categories—AI/ML, Healthcare, Bio, Robotics, Crypto, and Other—and targets technical founders who require both capital and credible domain engagement. Its 11-person team comprises Managing Partner Michael Dempsey, General Partner David Hirsch, CFO Tara Eckert, Partners 0xSmac and Shelby Newsad, Researcher Mackenzie Morehead, and five Venture Partners covering computational biology, data science & AI, biology, crypto, and AI & robotics.
Compound's core offering is research-driven deal-making, publicised through a Notion-hosted Thesis Database of 100+ investment theses and a content engine spanning the Compound Writing page, CompoundArxiv on Twitter/X, Substack newsletters, and a dedicated crypto sub-site (crypto.compound.vc). The firm uses this corpus as both internal investment framework and external marketing surface, positioning itself to attract founders whose work aligns with pre-published theses. Its business model is that of a small venture fund: economics flow from management fees and carried interest on invested capital, with deal flow sourced from public theses, syndication networks, and direct founder outreach.
Disclosed portfolio activity includes co-investments in SuppCo ($5.5M seed, October 2024) alongside Union Square Ventures, True Ventures, and Box Group; Cycles ($6.4M seed, May 2026) alongside Blockchange Ventures, Coinbase Ventures, and Primitive Ventures; and Orbital Industries ($50M Series B, May 2026) alongside Plural, NVentures (NVIDIA), Radical Ventures, and Fly Ventures. In 2026 the firm extended its research ethos outward via Compound Reverie Grants, a non-dilutive micro-grant program offering $500–$7,500 to researchers in machine learning, robotics, biology, healthcare, energy, and crypto. No firm-level AUM, fund size, or revenue figures are disclosed.
Compound firmographics
Firmographics- Name
- Compound
- Legal name
- Compound
- Website
- https://compound.vc/
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Compound is a New York-based, thesis-driven venture capital firm investing across AI/ML, biology, crypto, and robotics. It serves technical founders with capital and specialist Venture Partner support, publishes 100+ public investment theses, and operates a non-dilutive micro-grants program.
- Ownership category
- akta.pro rank
Compound industry classification
Industry- Product category
- Venture Capital
- NAICS
- Other Investment Pools and Funds (5259), Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Early-Stage Venture Capital (Series A/B) (FSANAAAB)
- akta.pro secondary industry
- SDG / Thematic Sustainable Investment Funds (FSANAJAN)
Keywords
Where Compound is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Compound business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Investment fund returns: As a thesis-driven venture investment firm, Compound generates economic returns (and fund-level revenue) through capital deployment into portfolio companies and co-investments alongside other investors. Specific fund economics (management fees, carried interest) are not publicly disclosed.
- Reverie Grants program (outbound capital): Outbound grant capital of $500 to $7,500 to researchers in cryonics, life extension, AGI safety, mind uploading; not a revenue stream but a capital deployment activity tied to thesis exploration.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Reverie Grants ($500 - $7,500) |
Go-to-market motion3 records
Distribution channels2 records
Marketing channels6 records
Compound product offering
Product offeringCore offering
Compound is a thesis-driven, research-centric venture capital investment firm that deploys capital into early-stage companies across six categories (AI/ML, Healthcare, Biology, Robotics, Crypto, and Other). It supports founders with domain expertise from specialist Venture Partners, publishes 100+ public investment theses via its Thesis Database and Writing platform, and operates the Compound Reverie Grants micro-grant program ($500–$7,500) for thesis-aligned and transitional researchers.
Product overview
Compound operates as a unified thesis-driven, research-centric investment firm rather than a traditional multi-product software platform; its public surface area consists of seven interconnected web properties that together form the firm's offering: the Compound Home landing page introducing the firm; the About Us team and mission page; the public Portfolio showcase across Automation (AI/ML/Robotics), Healthcare & Biology, Crypto, and Other categories; the Writing publication platform with essays authored by team members; the standalone Compound Thesis Database of 100 publicly available theses across six categories; the Compound Reverie Grants micro-grant program providing non-dilutive funding to edge-of-thesis explorers; and the Compound Crypto sub-site at crypto.compound.vc for crypto-focused content. The modules fit together as a stack in which the Home/About pages anchor the firm's positioning, the Portfolio demonstrates execution on those beliefs, the Writing and Thesis Database publish the underlying research, the Crypto sub-site drills into one of the six thesis categories, and Reverie Grants extends the firm's research ethos outward to non-venture grantees.
Differentiator
Problem solved
Functional benefit
Brands
- Compound Reverie Grants: Micro-grants program offering $500–$7,500 in non-dilutive funding for exploratory, thesis-aligned and transitional projects.
- Compound Crypto
Products and services
- Compound Reverie Grants Micro-grant program offering non-dilutive, no-strings-attached funding of $500 to $7,500 to individual researchers and transitional thinkers exploring ideas at the edges of the firm's thesis areas, including machine learning, robotics, biology, healthcare, energy, crypto, cryonics, life extension, AGI safety, and mind uploading.
- Thesis-Driven Venture Capital Investment Capital deployment into early-stage companies across six thesis categories (AI/ML, Healthcare, Biology, Robotics, Crypto, Other), paired with technical co-building from specialist Venture Partners who help founders solve technical problems, communicate breakthroughs, and scale commercialization.
Quantifiable outcome
- 100+ public theses published across 6 categories since 2016
- +2 more outcomes
Companies that use Compound
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
Compound technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Compound partnerships and signals
Strategic signalScale indicators6 records
Recent moves6 records
Expansion highlights5 records
Compound competitors and assessment
Company assessmentDirect peers
- Paradigm: Paradigm is a thesis-driven crypto/web3-focused investment firm that publishes research and operates with deep domain expertise. It is the closest comparable to Compound's crypto thesis-led, research-publishing model and overlapping crypto portfolio (e.g., investments in Arbitrum-adjacent infrastructure).
- Lux Capital: Lux Capital is a thesis-driven deep-tech VC investing in AI, robotics, biology, and frontier science with published research and a specialist partner model. It is directly comparable to Compound's bio/AI/robotics thesis-led approach and emphasis on scientifically deep founders.
- DCVC: DCVC (Data Collective) is a thesis-driven deep-tech VC that publishes deep research and invests in computational biology, AI, and engineering biology. It mirrors Compound's six-category, science-first thesis approach and its co-investor posture alongside tier-1 VCs.
- Arch Venture Partners: Arch Venture Partners is a thesis-driven deep-tech and biotech VC with deep domain expertise and specialist partners. It overlaps with Compound's biology/biotech thesis category and its emphasis on technically deep, science-first investing.
Emerging players
- Outset Capital: Outset Capital is an emerging thesis-driven, research-publishing AI investment firm. It overlaps with Compound's AI/ML & Robotics thesis category and similarly publishes public research as a deal-sourcing and brand-building tool, though at an earlier stage.
Broad incumbents
- Founders Fund: Founders Fund is a thesis-driven, broad-spectrum VC that publishes essays and bold theses to attract founders. It is comparable to Compound as a thesis-led, content-forward investment firm, but at a much larger scale and across a wider category set.
- Andreessen Horowitz (a16z): a16z is a broad incumbent thesis-driven VC with a dedicated crypto fund (a16z crypto) that publishes extensive research and operates large grant programs. It overlaps with Compound's crypto thesis category and content-led GTM, but at vastly greater scale and with a multi-stage, multi-product platform.
- Union Square Ventures: USV is a thesis-driven VC investing across crypto, consumer, and frontier tech, and is a confirmed co-investor with Compound (led SuppCo). It is comparable as a fellow thesis-led, content-publishing VC firm that participates in similar categories like crypto and consumer health.
- True Ventures: True Ventures is a thesis-driven seed/early-stage VC that has co-invested with Compound in SuppCo. It is comparable as a thesis-led investment firm focused on early-stage technical founders, though operating across a broader category set than Compound.
- Box Group: Box Group is a thesis-driven early-stage VC and a confirmed co-investor alongside Compound (in SuppCo). It is comparable as a similarly-sized thesis-led, content-publishing firm investing in deep-tech and crypto categories.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat3 records
Key risks4 records
Key highlights6 records
Customer concentration
Compound social profiles
Digital presenceCompound financial estimates
Financial estimateRevenue estimate
Valuation estimate
Compound leadership team
Management profileNumber of profiles
Profiles11 records
Compound subsidiaries and ownership
Company hierarchySubsidiaries1 record
Compound funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Compound M&A and investment
M&A and investmentM&A
Investments272 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Compound
What does Compound do?
Compound is a thesis-driven, research-centric venture capital investment firm that deploys capital into early-stage companies across six categories (AI/ML, Healthcare, Biology, Robotics, Crypto, and Other). It supports founders with domain expertise from specialist Venture Partners, publishes 100+ public investment theses via its Thesis Database and Writing platform, and operates the Compound Reverie Grants micro-grant program ($500–$7,500) for thesis-aligned and transitional researchers.
Is Compound a public or private company?
Compound is a private company. It is classified as management employee owned and is currently operating.
When was Compound founded?
Compound was founded in 2008. It employs 1 to 10 people.
Where is Compound based?
Compound is headquartered in New York, United States, in the North America region.
How does Compound make money?
Two revenue lines are on record. Investment fund returns are the primary driver. The others are reverie Grants program (outbound capital).
Who are Compound's main competitors?
Direct peers on record are Paradigm, Lux Capital, DCVC and Arch Venture Partners. Outset Capital is listed as an emerging player. Broad incumbents are Founders Fund, Andreessen Horowitz (a16z), Union Square Ventures, True Ventures and Box Group.
Does Compound have an API?
No public API is recorded for Compound.
What industry is Compound in?
Compound's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAB, Early-Stage Venture Capital (Series A/B), with a secondary code of FSANAJAN, SDG / Thematic Sustainable Investment Funds. Its NAICS code is 5259 and its SIC code is 6282.